Science Explorer Back to mapMap
Discussion
Researcher · Memorial Sloan Kettering Cancer Center · United States

Gregory J. Riely

Gregory J. Riely publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Lung Cancer Research Studies and Lung Cancer Diagnosis and Treatment.

ORCID 0000-0001-5357-4313 OpenAlex
World rank
#751
of 7,710,434 ranked researchers
Rank in United States
#340
of 1,627,098
Works
1,338
Citations
98k
Citations per work
73.0
h-index
131
i10-index 359Top 0.1% in Pulmonary and Respiratory Medicine
Gregory J. Riely

What does Gregory J. Riely research?

Gregory J. Riely's work is mostly in Medicine (69%), Biochemistry, Genetics and Molecular Biology (16%).

Health Sciences: 923 works · 69.0% of their workMedicine: 923 works · 69.0% of their workPulmonary and Respiratory Medicine: 535 works · 40.0% of their workOncology: 318 works · 23.8% of their workNeurology: 36 works · 2.7% of their workRadiology, Nuclear Medicine and Imaging: 33 works · 2.5% of their workLife Sciences: 218 works · 16.3% of their workBiochemistry, Genetics and Molecular Biology: 218 works · 16.3% of their workMolecular Biology: 111 works · 8.3% of their workCancer Research: 107 works · 8.0% of their workEverything else: 197 works · 14.7% of their workTHEIR WORKGregory J. Riely1,338works
Life Sciences16%Health Sciences69%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine92369.0%
    1. Biochemistry, Genetics and Molecular Biology21816.3%
  3. Everything else19714.7%
  1. 1Pulmonary and Respiratory Medicine40% of their works
  2. 2Oncology24% of their works
  3. 3Molecular Biology8% of their works
  4. 4Cancer Research8% of their works
  5. 5Neurology3% of their works
  6. 6Radiology, Nuclear Medicine and Imaging2% of their works

Research topics

Which keywords describe Gregory J. Riely's research?

The keywords of their largest research topics: Targeted Therapy, Clinical Trials, Chemotherapy, ALK Inhibitors, EGFR Mutations, Immunotherapy, Genomic Profiles and Small-Cell Lung Cancer.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Targeted Therapy7363 topics
  2. Clinical Trials6042 topics
  3. Chemotherapy4494 topics
  4. ALK Inhibitors4401 topic
  5. EGFR Mutations4401 topic
  6. Immunotherapy2052 topics
  7. Genomic Profiles1641 topic
  8. Small-Cell Lung Cancer1641 topic
  9. CT Screening1541 topic
  10. Lung Cancer1541 topic
  11. Cancer Genomics1321 topic
  12. Mutational Signatures1321 topic
  13. Cetuximab1011 topic
  14. KRAS Mutations1011 topic
  15. Immune Checkpoint Blockade621 topic
  16. PD-1 and PD-L1621 topic
  17. Myasthenia Gravis411 topic
  18. Thymic Tumors411 topic
  19. Breast Cancer301 topic
  20. HER2301 topic

Where does Gregory J. Riely work?

Gregory J. Riely's main affiliation in the publication record is Memorial Sloan Kettering Cancer Center, United States.

How many publications and citations does Gregory J. Riely have?

OpenAlex counts 1,338 works and 97,626 citations for Gregory J. Riely, an h-index of 131, ranking #751 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Gregory J. Riely. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.